Analyzing the forecast for Biotechnology R&D intensity in Belgium's business sector, the data shows a gradual increase in intensity from 2024 to 2028, where values rise from 0.08% to 0.088% of Value Added in Industry.
The year-on-year variation indicates a consistent increase of approximately 2.5% annually. Notably, from 2023 to 2024, the value remains steady at 0.08%. The Compound Annual Growth Rate (CAGR) over the last five years suggests an average annual increase of 2.5%.
Future trends to watch for include potential impacts of policy changes, advancements in biotech research and development, and the influence of global market dynamics on Belgium's biotech industry investments. Keeping track of these factors may provide further insights into sustaining and enhancing growth in R&D intensity.
